BSECCME Global Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 24 Nov, 2025 · 14:20 IST

Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors ('IDC') of Genesis Ibrc India Ltd ....

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.0%Reaction day
₹158.30
prior close
₹155.15
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-1.4% vs market
Pharmaceuticals & Biotechnology peers, median of 159sector · industry level-0.8%-1.2% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.0-0.6-1.4-0.8-1.2
Next day
-3.9-0.5-3.5-0.7-3.2
2d
-5.8+0.8-6.7+0.2-6.1
3d
-7.7+0.4-8.1-0.5-7.2
4d
-9.3+0.3-9.6-0.1-9.2
5d
-13.8+0.1-13.9-0.4-13.4
1w
-22.2-1.0-21.2-1.1-21.1
15d
-45.6-2.5-43.1-1.7-43.8
1m
-40.6-2.2-38.4-1.5-39.1
2m
-50.6-10.8-39.8-9.2-41.4
3m
-50.4-7.0-43.4-9.5-40.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals & Biotechnology peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Padmanaban Krishnamoorthy and Ms. V Varalakshmi (the Acquirers) have made an Open Offer to buy up to 26,40,039 shares (20.31% of voting share capital) from public shareholders of Genesis IBRC India Limited at ₹7.00 per share, totaling a maximum consideration of ₹1.84 crore. This offer is triggered under SEBI Takeover Regulations following a Share Purchase Agreement where the Acquirers agreed to buy 14,73,000 shares (11.33%) from a Selling Promoter Shareholder at ₹7.00 per share, aggregating to ₹1.03 crore. The Acquirers already hold 72,69,500 shares (55.92%) of the Target Company. The Committee of Independent Directors of Genesis IBRC India has published its recommendations on this offer in leading newspapers on November 24, 2025.

Likely market impact

Public shareholders of Genesis IBRC India now have a formal window to tender their shares at ₹7.00 per share in cash. Existing shareholders should review the IDC recommendations published in Financial Express, Jansatta, Mumbai Lakshadeep, and Saksham Daily before deciding to participate in the offer.